Cite
A tumour-spheroid manufacturing and cryopreservation process that yields a highly reproducible product ready for direct use in drug screening assays.
MLA
Shajib, Md Shafiullah, et al. “A Tumour-Spheroid Manufacturing and Cryopreservation Process That Yields a Highly Reproducible Product Ready for Direct Use in Drug Screening Assays.” Journal of the Royal Society, Interface, vol. 20, no. 207, Oct. 2023, p. 20230468. EBSCOhost, https://doi.org/10.1098/rsif.2023.0468.
APA
Shajib, M. S., Futrega, K., Davies, A. M., Franco, R. A. G., McKenna, E., Guillesser, B., Klein, T. J., Crawford, R. W., & Doran, M. R. (2023). A tumour-spheroid manufacturing and cryopreservation process that yields a highly reproducible product ready for direct use in drug screening assays. Journal of the Royal Society, Interface, 20(207), 20230468. https://doi.org/10.1098/rsif.2023.0468
Chicago
Shajib, Md Shafiullah, Kathryn Futrega, Anthony M Davies, Rose Ann G Franco, Eamonn McKenna, Bianca Guillesser, Travis J Klein, Ross W Crawford, and Michael R Doran. 2023. “A Tumour-Spheroid Manufacturing and Cryopreservation Process That Yields a Highly Reproducible Product Ready for Direct Use in Drug Screening Assays.” Journal of the Royal Society, Interface 20 (207): 20230468. doi:10.1098/rsif.2023.0468.